GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scinai Immunotherapeutics Ltd (NAS:SCNI) » Definitions » E10

Scinai Immunotherapeutics (Scinai Immunotherapeutics) E10 : $-16.96 (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Scinai Immunotherapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scinai Immunotherapeutics's adjusted earnings per share data for the three months ended in Sep. 2023 was $0.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-16.96 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-29), Scinai Immunotherapeutics's current stock price is $0.45783. Scinai Immunotherapeutics's E10 for the quarter that ended in Sep. 2023 was $-16.96. Scinai Immunotherapeutics's Shiller PE Ratio of today is .


Scinai Immunotherapeutics E10 Historical Data

The historical data trend for Scinai Immunotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinai Immunotherapeutics E10 Chart

Scinai Immunotherapeutics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -17.27

Scinai Immunotherapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -17.27 -17.24 -17.11 -16.96

Competitive Comparison of Scinai Immunotherapeutics's E10

For the Biotechnology subindustry, Scinai Immunotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinai Immunotherapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scinai Immunotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scinai Immunotherapeutics's Shiller PE Ratio falls into.



Scinai Immunotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinai Immunotherapeutics's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.8/129.8595*129.8595
=0.800

Current CPI (Sep. 2023) = 129.8595.

Scinai Immunotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201312 -2.030 98.326 -2.681
201403 -1.719 99.695 -2.239
201406 -1.982 100.560 -2.559
201409 -1.495 100.428 -1.933
201412 -1.128 99.070 -1.479
201503 -1.672 99.621 -2.180
201506 -5.291 100.684 -6.824
201509 0.101 100.392 0.131
201512 -3.121 99.792 -4.061
201603 -1.058 100.470 -1.367
201606 -2.075 101.688 -2.650
201609 -2.131 101.861 -2.717
201612 -1.952 101.863 -2.489
201703 -7.728 102.862 -9.756
201706 -8.028 103.349 -10.087
201709 1.133 104.136 1.413
201712 -5.966 104.011 -7.449
201803 -5.695 105.290 -7.024
201806 -10.934 106.317 -13.355
201809 -1.107 106.507 -1.350
201812 -18.395 105.998 -22.536
201903 0.221 107.251 0.268
201906 -20.146 108.070 -24.208
201909 -5.741 108.329 -6.882
201912 -11.709 108.420 -14.024
202003 -1.120 108.902 -1.336
202006 -11.603 108.767 -13.853
202009 11.600 109.815 13.717
202012 -3.564 109.897 -4.211
202103 -2.396 111.754 -2.784
202106 -3.686 114.631 -4.176
202109 -2.484 115.734 -2.787
202112 -1.789 117.630 -1.975
202203 -1.200 121.301 -1.285
202206 -1.600 125.017 -1.662
202209 4.000 125.227 4.148
202212 -3.600 125.222 -3.733
202303 -1.200 127.348 -1.224
202306 -1.200 128.729 -1.211
202309 0.800 129.860 0.800

Add all the adjusted EPS together and divide 10 will get our e10.


Scinai Immunotherapeutics  (NAS:SCNI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scinai Immunotherapeutics E10 Related Terms

Thank you for viewing the detailed overview of Scinai Immunotherapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Scinai Immunotherapeutics (Scinai Immunotherapeutics) Business Description

Traded in Other Exchanges
Address
Hadassah Ein Kerem Campus, Jerusalem BioPark, 2nd Floor, Jerusalem, ISR
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Executives
Samuel J Moed director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Mark Germain director, other: Chairman WELLSFORD REAL PROPERTIES INC, 535 MADISON AVENUE, NEW YORK NY 10022
Uri Ben-or officer: Chief Financial Officer C/O BIOMX LTD., 7 PINHAS SAPIR ST., FLOOR 2, NESS ZIONA L3 7414002
Yael Margolin director 4850 WEST 78TH STREET, INDIANAPOLIS IN 46268
Adi Raviv director STRAUS CAPITAL GROUP, 411 HACKENSACK AVENUE, 7TH FLOOR, HACKENSACK NJ 07601
Morris C Laster director 11 REUVEN SHARI ST., JERUSALEM L3 9724611
Tamar Ben-yedidia officer: Chief Scientist 6 HAZIT ST., MAZKERET BATIA L3 7685421
Avner Rotman director 21 EISENBERG ST., REHOVOT L3 7628905
Amir Reichman director, officer: Chief Executive Officer 269 NAHAL FARAN ST., TAL SHAHAR L3 7680500
Elad Mark officer: Chief Operating Officer 27 HAILANOT, HERZLIYA L3 4631214
George Lowell director 33 DERECH BEIT LECHEM ST., JERUSALEM L3 9355317
Jay Green director 354 CONCESSION 10 E, FREELTON, ON Z4 L8B 1H6